Intermittent Fasting Modulates Immune Response by Generating Tregs Via TGF-β Dependent Mechanisms in Obese Mice with Allergic Contact Dermatitis
Overview
Authors
Affiliations
People with obesity maintain low levels of inflammation; therefore, their exposure to foreign antigens can trigger an excessive immune response. In people with obesity or allergic contact dermatitis (ACD), symptoms are exacerbated by a reduction in the number of regulatory T cells (Tregs) and IL-10/TGF-β-modified macrophages (M2 macrophages) at the inflammatory site. Benefits of intermittent fasting (IF) have been demonstrated for many diseases; however, the immune responses regulated by macrophages and CD4T cells in obese ACD animal models are poorly understood. Therefore, we investigated whether IF suppresses inflammatory responses and upregulates the generation of Tregs and M2 macrophages in experimental ACD animal models of obese mice. The IF regimen relieved various ACD symptoms in inflamed and adipose tissues. We showed that the IF regimen upregulates Treg generation in a TGF-β-dependent manner and induces CD4T cell hypo-responsiveness. IF-M2 macrophages, which strongly express TGF-β and inhibit CD4T cell proliferation, directly regulated Treg differentiation from CD4T cells. These results indicate that the IF regimen enhances the TGF-β-producing ability of M2 macrophages and that the development of Tregs keeps mice healthy against ACD exacerbated by obesity. Therefore, the IF regimen may ameliorate inflammatory immune disorders caused by obesity.
Neuroimmune axis: Linking environmental factors to pancreatic β-cell dysfunction in Diabetes.
Andreone L Brain Behav Immun Health. 2025; 43():100926.
PMID: 39810797 PMC: 11732196. DOI: 10.1016/j.bbih.2024.100926.
Emerging and Promising Keywords in Biomolecules and Therapeutics for 21st Century Diseases.
Ko H, Lee C Biomol Ther (Seoul). 2024; 33(1):1-4.
PMID: 39725476 PMC: 11704395. DOI: 10.4062/biomolther.2024.007.
Guo M, Fang W, Hu Z Front Immunol. 2024; 15():1429483.
PMID: 39660124 PMC: 11628391. DOI: 10.3389/fimmu.2024.1429483.
Chen X, Fu C, Zheng Y, Li X, Liao Y, Zheng Y Arch Dermatol Res. 2024; 316(5):176.
PMID: 38758283 DOI: 10.1007/s00403-024-02886-5.
Noval advance of histone modification in inflammatory skin diseases and related treatment methods.
Zhang L, Chai R, Tai Z, Miao F, Shi X, Chen Z Front Immunol. 2024; 14:1286776.
PMID: 38235133 PMC: 10792063. DOI: 10.3389/fimmu.2023.1286776.